Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
about
Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heartA novel compound NSC745885 exerts an anti-tumor effect on tongue cancer SAS cells in vitro and in vivoInfluence of intermittent hypoxia on myocardial and hepatic P-glycoprotein expression in a rodent modelAetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data.Tachycardia-induced heart failure does not alter myocardial P-glycoprotein expression.Impact of ABCB1 allelic variants on QTc interval prolongation.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyHyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.P glycoprotein in human immunodeficiency virus type 1 infection and therapy.[¹¹C]Rhodamine-123: synthesis and biodistribution in rodents.In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity.Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.An introduction to the metabolic determinants of anthracycline cardiotoxicity.Transporter-mediated uptake into cellular compartments.Pharmacogenetics of membrane transporters: an update on current approaches.Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapyFunctional characterization of drug uptake and metabolism in the heart.Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia.Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples.Heart and systemic effects of statin pretreatment in a rat model of abdominal sepsis. Assessment by Tc99m-sestamibi biodistribition.Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.A novel screening strategy to identify ABCB1 substrates and inhibitors.Increased efflux of glutathione conjugate in acutely diabetic cardiomyocytes.Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out mice.Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.Modeling cardiac uptake and negative inotropic response of verapamil in rat heart: effect of amiodarone.Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein.Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein.Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.Expression of the MDR-1 gene-encoded P-glycoprotein in cardiomyocytes of conscious sheep undergoing acute myocardial ischemia followed by reperfusion.Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians
P2860
Q24685159-9B83816F-94A7-4F5A-8B6E-0C2A6DB32832Q28541985-502C29A9-7B9A-40E1-99E3-6B15A3809172Q28576207-6AE82667-7440-4FFE-8969-10AFA26F3F28Q31043414-9FD4455F-E55C-4F01-A77A-9823B57F5860Q33197068-021F0A00-1866-4674-88B7-0945BCF52DDFQ34781769-B70FF903-1CCF-45A1-AEEA-972E67D0D4CFQ35071386-4D5DB694-288C-42D7-9105-FDE556E9CC51Q35086334-63CCA8F6-96F2-47F4-A933-B2CC0EE62B85Q35718765-2BC285C9-9CE2-4AFE-9797-7D35CA280D91Q36339071-571F6ABD-B5C0-4191-8DF0-1551CF22E115Q36619383-4539F230-373D-41F2-8CA7-45C318B79229Q36691249-D3012265-AFDF-4DC9-A7D6-86DA240A1A55Q36891719-F0BBE52C-F155-49B3-BDFC-1316BFB09E8DQ36985076-D2AD0ECD-176B-4026-B9D0-481D0553EC35Q37641869-E4A10436-0D64-4D75-8F2D-4DE37997BA6FQ37735146-A7174CAD-2DD8-4216-86FC-636773D50890Q37922773-98431417-9155-4AE7-BADF-927FD3CCB705Q39233839-AD8029E2-4004-474E-95CA-518970EFA67CQ39240358-B2B58B87-5C43-4406-BE61-7A8B6AC3673EQ39539298-C85FB90D-2BA3-4602-BFFA-9CCD60F177F3Q41141888-A7896D65-51BF-41F9-A77F-8FE8FF2276E8Q42284764-A41535E1-2C37-4AA1-BC5E-B64B243D4483Q44231662-179D5D18-029F-4A85-A7CE-70B38BF4DDEAQ45169159-B7C60082-D17B-49A4-81F3-B12863A58627Q46111736-CC8A10CD-161E-4003-9CFE-5DDF6BD5301DQ50026018-6E49CCF4-CF1F-491D-9F35-DD808A860A3BQ51933560-0DFA54DC-3EF7-4191-AF6C-ED38A71D0412Q52964010-9658A34A-FEE9-4CFE-AF11-0F188AFEFBF9Q53579317-1F242C9E-5DFC-42C9-BB62-5160EE23F125Q54532089-7EF92D59-7C42-4C0C-AED2-93738347BB83Q54571676-A7B47952-D82D-4823-9021-3AD8497CF24EQ57749429-9C776946-1102-4C6D-AA6C-BF06B10C92D2
P2860
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
@en
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
@nl
type
label
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
@en
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
@nl
prefLabel
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
@en
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy.
@nl
P2093
P2860
P1476
Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy
@en
P2093
Bernhard Sperker
Christiane Karsten
Christiane Kunert-Keil
Heyo K Kroemer
Konrad Meissner
Michael Böhm
Michael Wendt
Peter Dazert
Rolf Warzok
Sandra Bien
P2860
P304
P356
10.1177/002215540205001008
P577
2002-10-01T00:00:00Z